Perigon Wealth Management’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
Perigon Wealth Management's BNTX Position: Q3 2026 in Review
Perigon Wealth Management reduced its BioNTech (BNTX) stake by 1.4% in Q3 2026, selling an estimated $8.16K and leaving 5,753 shares worth $566K. The position accounts for 0.01% of the portfolio, ranked #842.
Perigon Wealth Management first reported a position in BNTX in Q1 2022 and has held it in 19 quarters since. The position peaked at $674K in Q3 2024. 113 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.
- Perigon Wealth Management held 5,753 shares of BioNTech worth $566K as of Q3 2026.
- Perigon Wealth Management sold 84 BioNTech shares in Q3 2026, an estimated $8.16K.
- BioNTech made up 0.01% of Perigon Wealth Management's portfolio in Q3 2026, its #842 holding.
- Perigon Wealth Management first reported a position in BioNTech in Q1 2022 and has held it in 19 quarters since.
- Perigon Wealth Management's BioNTech position peaked at $674K in Q3 2024.
- 113 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.
Based on Perigon Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.